Effectiveness of targeted antenatal family planning information provision on early postpartum family planning uptake in Kisumu county: Study protocol for a Simple Randomized …

Abstract

Overlooking the contraceptive needs of postpartum women constitutes missed opportunities in health system. Inter-birth interval of at least three years can prevent poor maternal, perinatal and neonatal outcomes and afford women socioeconomic benefits of family planning (FP). The unmet need for FP in the postpartum period remains unacceptably high and far exceeds the FP unmet need of other women. The Kenya Demographic and Health Survey (KDHS) estimate the unmet need for postpartum FP to be 74%. Maternal and Child Health (MCH) continuum provides a great opportunity for postpartum FP (PPFP) interventions integration especially Antenatal targeted FP information giving and gauging fertility intentions. However, there is no protocol for structured, targeted Antenatal FP information giving and behavioural contracting to influence postpartum fertility intentions of mothers before delivery. Knowledge gap regarding fertility intentions and best antenatal strategies for postpartum FP still exists. The available evidence differs across settings and demography. Equally, there has been inadequate exploration of operationally-feasible ways to integrate FP counselling into existing ANC services with limited number of methodologically rigorous trials. This study will therefore examine the effectiveness of antenatal family planning information provision on early postpartum FP uptake using a randomized control trial in Kisumu. The researcher will; assess socio-cultural beliefs towards of PPFP and perceived individual control of PPFP choice, analyze knowledge and intention for PPFP, compare and examine the determinants of PPFP uptake between study groups. A group of 246 antenatal mothers will be randomly assigned to control, community and facility intervention groups as per eligibility criteria in the study facilities that will be cluster sampled. After at least 3 months of intervention and 3 months of postpartum follow-up, clinical superiority will be used to gauge which invention was effective and the model superiority. Questionnaire and Case Report Forms will be the main source of data. The participant will form the unit of analysis which will be by intention to treat. Bivariate analysis will be done as the selection criteria for inclusion of predictors of intention and uptake with a P≤ 0.05 in the final logistic regression model. P-values, ≤0.05, Odds Ratios and 95% confidence interval (CI) will be used to demonstrate significance and the strength of association between selected variables. Dissemination will be through conference presentations and peer reviewed journals. The trial has been registered with the Pan African Clinical Trials Registry PACTR202109586388973 on the 28th September 2021.